Overview

Open-label Safety Extension Study of Gevokizumab in Erosive Osteoarthritis of the Hand

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety of gevokizumab in the treatment of active inflammatory, erosive osteoarthritis of the hand.
Phase:
N/A
Details
Lead Sponsor:
XOMA (US) LLC